Is Chromadex Corp Stock a Good Investment?
Chromadex Corp Investment Advice | CDXC |
- Examine Chromadex Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Chromadex Corp's leadership team and their track record. Good management can help Chromadex Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Life Sciences Tools & Services space and any emerging trends that could impact Chromadex Corp's business and its evolving consumer preferences.
- Compare Chromadex Corp's performance and market position to its competitors. Analyze how Chromadex Corp is positioned in terms of product offerings, innovation, and market share.
- Check if Chromadex Corp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Chromadex Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Chromadex Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Chromadex Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Good | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Chromadex Corp Stock
Researching Chromadex Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 35.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Chromadex Corp had 1:3 split on the 13th of April 2016.
To determine if Chromadex Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chromadex Corp's research are outlined below:
| Chromadex Corp is way too risky over 90 days horizon | |
| Chromadex Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 83.57 M. Net Loss for the year was (4.94 M) with profit before overhead, payroll, taxes, and interest of 42.8 M. | |
| Chromadex Corp has a poor financial position based on the latest SEC disclosures | |
| About 35.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: StockNews.com Downgrades ChromaDex to Buy |
Chromadex Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chromadex Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chromadex Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Chromadex Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Chromadex Corp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-31 | 2024-09-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2024-05-08 | 2024-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2023-08-09 | 2023-06-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2022-08-10 | 2022-06-30 | -0.08 | -0.09 | -0.01 | 12 | ||
2021-03-10 | 2020-12-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2024-08-07 | 2024-06-30 | -0.02 | -2.0E-4 | 0.0198 | 99 | ||
2023-11-08 | 2023-09-30 | -0.03 | -0.01 | 0.02 | 66 | ||
2023-05-10 | 2023-03-31 | -0.05 | -0.03 | 0.02 | 40 |
Know Chromadex Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chromadex Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chromadex Corp backward and forwards among themselves. Chromadex Corp's institutional investor refers to the entity that pools money to purchase Chromadex Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-06-30 | 199.6 K | Millennium Management Llc | 2024-06-30 | 192.3 K | Bank Of New York Mellon Corp | 2024-06-30 | 190.4 K | Winton Capital Group Ltd | 2024-09-30 | 178.1 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 158.1 K | Charles Schwab Investment Management Inc | 2024-09-30 | 140.2 K | Ubs Group Ag | 2024-06-30 | 139.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 139.5 K | Strs Ohio | 2024-09-30 | 104.1 K | Vanguard Group Inc | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 3.1 M |
Chromadex Corp's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 582.8 M.Market Cap |
|
Chromadex Corp's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.10) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.17) | (0.18) |
Determining Chromadex Corp's profitability involves analyzing its financial statements and using various financial metrics to determine if Chromadex Corp is a good buy. For example, gross profit margin measures Chromadex Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chromadex Corp's profitability and make more informed investment decisions.
Please note, the presentation of Chromadex Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chromadex Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chromadex Corp's management manipulating its earnings.
Evaluate Chromadex Corp's management efficiency
As of November 23, 2024, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Chromadex Corp's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 28.4 M. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.38 | 0.24 | |
| Tangible Book Value Per Share | 0.37 | 0.23 | |
| Enterprise Value Over EBITDA | (21.36) | (22.43) | |
| Price Book Value Ratio | 3.77 | 3.58 | |
| Enterprise Value Multiple | (21.36) | (22.43) | |
| Price Fair Value | 3.77 | 3.58 | |
| Enterprise Value | 205.9 M | 216.2 M |
The management strategies employed by Chromadex Corp's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta 1.88 |
Basic technical analysis of Chromadex Stock
As of the 23rd of November, Chromadex Corp shows the Downside Deviation of 2.73, risk adjusted performance of 0.1369, and Mean Deviation of 4.09. Chromadex Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Chromadex Corp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chromadex Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chromadex Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chromadex Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chromadex Corp's Outstanding Corporate Bonds
Chromadex Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chromadex Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chromadex bonds can be classified according to their maturity, which is the date when Chromadex Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| CHRISTUS HEALTH 4341 Corp BondUS17108JAA16 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Chromadex Corp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Chromadex Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1369 | |||
| Market Risk Adjusted Performance | (1.74) | |||
| Mean Deviation | 4.09 | |||
| Semi Deviation | 2.04 | |||
| Downside Deviation | 2.73 | |||
| Coefficient Of Variation | 600.23 | |||
| Standard Deviation | 9.07 | |||
| Variance | 82.32 | |||
| Information Ratio | 0.1522 | |||
| Jensen Alpha | 1.61 | |||
| Total Risk Alpha | 0.0727 | |||
| Sortino Ratio | 0.5052 | |||
| Treynor Ratio | (1.75) | |||
| Maximum Drawdown | 73.19 | |||
| Value At Risk | (3.99) | |||
| Potential Upside | 6.69 | |||
| Downside Variance | 7.47 | |||
| Semi Variance | 4.18 | |||
| Expected Short fall | (6.02) | |||
| Skewness | 6.23 | |||
| Kurtosis | 45.36 |
| Risk Adjusted Performance | 0.1369 | |||
| Market Risk Adjusted Performance | (1.74) | |||
| Mean Deviation | 4.09 | |||
| Semi Deviation | 2.04 | |||
| Downside Deviation | 2.73 | |||
| Coefficient Of Variation | 600.23 | |||
| Standard Deviation | 9.07 | |||
| Variance | 82.32 | |||
| Information Ratio | 0.1522 | |||
| Jensen Alpha | 1.61 | |||
| Total Risk Alpha | 0.0727 | |||
| Sortino Ratio | 0.5052 | |||
| Treynor Ratio | (1.75) | |||
| Maximum Drawdown | 73.19 | |||
| Value At Risk | (3.99) | |||
| Potential Upside | 6.69 | |||
| Downside Variance | 7.47 | |||
| Semi Variance | 4.18 | |||
| Expected Short fall | (6.02) | |||
| Skewness | 6.23 | |||
| Kurtosis | 45.36 |
Consider Chromadex Corp's intraday indicators
Chromadex Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chromadex Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Chromadex Corp Corporate Filings
8K | 21st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 8th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 26th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Chromadex Stock media impact
Far too much social signal, news, headlines, and media speculation about Chromadex Corp that are available to investors today. That information is available publicly through Chromadex media outlets and privately through word of mouth or via Chromadex internal channels. However, regardless of the origin, that massive amount of Chromadex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chromadex Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chromadex Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chromadex Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chromadex Corp alpha.
Chromadex Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Chromadex Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Chromadex Corp Corporate Management
| Kendall Knysch | Head Partnerships | Profile | |
| Heather Blarcom | Senior Secretary | Profile | |
| Andrew Shao | Senior Affairs | Profile | |
| Chu Yan | Managing Pacific | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Chromadex Corp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.